Loading
WP
Wanbangde Pharmaceutical Holding Group Co., Ltd. Stock: price and insider trades · China
ST万邦
Wanbangde Pharmaceutical Holding Group Co., Ltd.: what insiders have been doing
Every trade that managers of Wanbangde Pharmaceutical Holding Group Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. No insider at Wanbangde Pharmaceutical Holding Group Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 13 October 2025.
Since 2025, the database holds no purchases and 2 sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€20M
2 ops. · all time
Who traded when
BuySale庄惠1 sale
赵守明1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 17,842 of 24,158 companies
35.5
score / 100
Value43
Quality28
FCF yld4.0%
Earn yld-2.1%
EV/EBITDA·
ROE-4.5%
Gross mgn35%
Net mgn-15%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥12.97
Analyst consensus
Income statement
RevenueCN¥1.1B
Gross profitCN¥390.4M35% margin
EBITDA-CN¥8.1M-1% margin
Net income-CN¥167.2M-10.4% margin
Valuation
P/Book3.1x
Beta-0.01
Balance sheet & cash
Market capCN¥7.9B
Total debtCN¥985.1M
Free Cash FlowCN¥314.3M
Debt / Equity38%
Profitability & ownership
ROE-4.5%
ROA-1.1%
% insiders53.5%
% institutions2.7%
Last declaration on 13 October 2025
About Wanbangde Pharmaceutical Holding Group Co., Ltd.
ST万邦 is a company in the healthcare and pharmaceutical sector, listed on the XSHE market. It specializes in the development and marketing of pharmaceutical products.
